Attached files

file filename
EX-10.52 - EX-10.52 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1052.htm
EX-10.32 - EX-10.32 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1032.htm
EX-31.1 - EX-31.1 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex311.htm
EX-32 - EX-32 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex321.htm
EX-31.2 - EX-31.2 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex312.htm
EX-23 - EX-23 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex23.htm
EX-21 - EX-21 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex21.htm
EX-10.66 - EX-10.66 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1066.htm
EX-10.65 - EX-10.65 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1065.htm
EX-10.63 - EX-10.63 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1063.htm
EX-10.62 - EX-10.62 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1062.htm
EX-10.61 - EX-10.61 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1061.htm
EX-10.60 - EX-10.60 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1060.htm
EX-10.59 - EX-10.59 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1059.htm
EX-10.58 - EX-10.58 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1058.htm
EX-10.57 - EX-10.57 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1057.htm
EX-10.56 - EX-10.56 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1056.htm
EX-10.55 - EX-10.55 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1055.htm
EX-10.54 - EX-10.54 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1054.htm
EX-10.53 - EX-10.53 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1053.htm
EX-10.51 - EX-10.51 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1051.htm
EX-10.50 - EX-10.50 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1050.htm
EX-10.49 - EX-10.49 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1049.htm
EX-10.46 - EX-10.46 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1046.htm
EX-10.45 - EX-10.45 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1045.htm
EX-10.44 - EX-10.44 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1044.htm
EX-10.43 - EX-10.43 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1043.htm
EX-10.42 - EX-10.42 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1042.htm
EX-10.41 - EX-10.41 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1041.htm
EX-10.40 - EX-10.40 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1040.htm
EX-10.39 - EX-10.39 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1039.htm
EX-10.38 - EX-10.38 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1038.htm
EX-10.37 - EX-10.37 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1037.htm
EX-10.36 - EX-10.36 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1036.htm
EX-10.35 - EX-10.35 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1035.htm
EX-10.34 - EX-10.34 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1034.htm
EX-10.33 - EX-10.33 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1033.htm
EX-10.31 - EX-10.31 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1031.htm
EX-10.30 - EX-10.30 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1030.htm
EX-10.29 - EX-10.29 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1029.htm
EX-10.28 - EX-10.28 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1028.htm
EX-10.27 - EX-10.27 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1027.htm
EX-10.26 - EX-10.26 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1026.htm
EX-10.25 - EX-10.25 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1025.htm
EX-10.24 - EX-10.24 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1024.htm
EX-10.23 - EX-10.23 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1023.htm
EX-10.22 - EX-10.22 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1022.htm
EX-10.21 - EX-10.21 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1021.htm
EX-10.20 - EX-10.20 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex1020.htm
EX-10.8 - EX-10.8 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex108.htm
EX-10.7 - EX-10.7 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex107.htm
EX-10.6 - EX-10.6 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex106.htm
EX-3.3 - EX-3.3 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex33.htm
EX-3.2 - EX-3.2 - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462dex32.htm
10-K - FORM 10-K - TEVA PHARMACEUTICAL INDUSTRIES LTDd529462d10k.htm

Exhibit 10.64

 

LOGO   

 

Private & Confidential

  

 

February 8, 2018

To: <First_Name> <Last_Name>

Teva Global ID: <GID>

Subject: 2018 Annual Bonus Plan for Employee Office Holders

Dear <First_Name>,

I would like to inform you that your eligibility for annual cash bonus for 2018 will be based on the following scheme:

 

LOGO

EPS: non-GAAP earnings per share as reported in the Teva Pharmaceutical Industries, Ltd. annual report on form 10-K, vs. AOP target

 

    Weight = 50%

 

    Cap = maximum achievement of 120%

 

    Super-measure: achievement of less than 85% of target Non-GAAP EPS will not entitle employees to Annual Bonus.

FCF (Free Cash Flow): cash from operations as reported in the Teva Pharmaceutical Industries Ltd. audited financial statements net of CAPEX, vs. AOP target

 

    Weight = 25%

 

    Cap = maximum achievement of 120%

 

    Super-measure: achievement of less than 85% of FCF target will not entitle employees to Annual Bonus.

Individual Performance:

 

    Weight = 25%

 

    Linked to performance evaluation ratings, each of which has an individual performance range:

 

LOGO

Scaled Performance Result:

In the range of 0% to 200%, determined by scaling the performance result up/down at a ratio of 1:5 (5% for each percentile change in performance).


LOGO   

 

Private & Confidential

  

 

February 8, 2018

Threshold:

Achievement of less than 85% of performance (weighted result before scaling) will not entitle office holders to Annual Bonus (achievement of 85% of performance will result in 25% after scaling).

Annual Base Salary (ABS): the eligible salary which is used for the Annual Bonus calculation and payout.

Target Bonus: 100%.

Notes:

 

    All components shall be calculated on a prorated basis (for example the Annual Base Salary in case of working less than a full year or salary change)

 

    Subject to your employment agreement, the Annual Bonus is and shall remain subject to your continued employment at the date of payout, the Compensation Policy and other company policies, including but not limited to clawback provisions, and to any applicable law

 

    The Annual Base Salary shall not include any statutory allowances, benefits or perquisites

 

    Teva reserves the right to amend or discontinue the plan at any time

We strongly believe in the company and in your contribution to its success. We look forward to your continued commitment towards Teva’s short and long-term strategic goals.

Sincerely,

 

/s/ Kåre Schultz

Kåre Schultz    

President and Chief Executive Officer